Document:

CONSULTING
SERVICES AGREEMENT

     

    THIS
CONSULTING SERVICES AGREEMENT (the “Agreement”) is entered into on November 15,
2007 between Lantis Laser Inc. (LLSR) (“Company”) and Debbie Sutz, having its
principal address at 24748 Long Valley Rd., Calabasas CA 91302
(“Consultant”).

     

    WHEREAS,
the Company desires to retain the services of Consultant as described herein and
Consultant desires to provide such services for the consideration set forth
below and for such other mutual promises and consideration received the Company
and Consultant hereby enter into this Agreement as follows:

     

    
      	
            	
              1.

            	
              Services.  The
      Company retains Consultant to render to the Company the following services
      (the “Services”):

            

    

     

    
      	
            	
              a)

            	
              Consultant
      will provide advisory and consulting services to the Company in
      conjunction with the development of the Company’s marketing plan, business
      plan and goals.  Consultant will also utilize icecoldstocks.com
      and any other media portal at their
disposal.

            

    

     

    
      	
            	
              b)

            	
              Consultant
      shall provide advisory and consulting services alternatives for maximizing
      the Company’s exposure to, and penetration of, its target
      market.

            

    

     

    
      	
            	
              c)

            	
              In
      consultation with the Company, Consultant shall schedule and arrange
      meetings and conferences, in person, by telephone, or other media, for the
      Company’s representatives and such third parties as the Consultant
      believes will further the purposes of this Agreement.  Said
      meetings and conferences shall be with representatives of potential
      strategic partners of the Company, marketing and media representatives and
      representatives of investment and banking advisory
    services.

            

    

     

    
      	
            	
              d)

            	
              It
      is expressly agreed herein that the Company shall be responsible for all
      reasonable costs and necessary expenses incurred by Consultant, including
      travel, mileage, duplicating and communication expenses.  The
      Company shall reimburse Consultant for all such expenses with thirty (30)
      days, subject to submission by Consultant of reasonably satisfactory
      documentation.  Consultant shall be required to receive prior
      written approval from the Company’s Chief Financial Officer or a member of
      the Board.

            

    

     

    
      	
            	
              2.

            	
              Compensation.  As
      consideration for Consultant’s performance of the Services, the Company
      agrees to issue to Ice Cold Stocks in the name of Var Growth Corp., Three
      million Five hundred thousand (3,500,000) shares of the Company’s
      restricted common stock upon the signing of this
      contract.  Further, if requested by Consultant or nominee, the
      Company shall at its sole expense, provide Consultant with a written legal
      opinion regarding the tradability of such stock upon the termination of
      the period of restriction.  The Company and Consultant agree to
      the following:

            

    

    
      	
              ICS
      Consulting Agreement 001

            	
              1

            	
              Initial______________

            

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              (i)

            	
              The
      following legend (or a legend substantially in the following form) shall
      be placed on certificates representing the Shares issued pursuant to this
      Section 2:

            

    

    

    THE
SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE
SECURITIES LAW, AND NO INTEREST THEREIN MAY BE SOLD, DISTRIBUTED, ASSIGNED,
OFFERED, PLEDGED OR OTHERWISE TRANSFERRED OR DISPOSED OF UNLESS (A) THERE IS AN
EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE UNITED STATES
STATE SECURITIES LAWS COVERING ANY SUCH TRANSACTION INVOLVING SAID SECURITIES,
OR (B) THIS CORPORATION RECEIVES AN OPINION OF LEGAL COUNSEL FOR THE HOLDER OF
THESE SECURITIES (CONCURRED IN BY LEGAL COUNSEL FOR THIS CORPORATION) STATING
THAT SUCH TRANSACTION IS EXEMPT FROM REGISTRATION, OR (C) THIS CORPORATION
OTHERWISE SATISFIES ITSELF THAT SUCH TRANSACTION IS EXEMPT FROM
REGISTRATION.

    

    Additionally,
the Consultant understands that at the present time Rule 144 promulgated under
the Securities Act may not be relied upon for the resale or distribution of the
securities issued pursuant to this Section 2, except and unless as to Rule
144(k) should Rule 144(k) become applicable to the Consultant, because the
Company does not file current or periodic reports with the Securities and
Exchange Commission or make information about the Company publicly
available.  Moreover, there can be no assurance that the Company will
in the future file such reports or make publicly available such
information.

    

      
        	
                ICS
      Consulting Agreement 001

              	
                2

              	
                Initial______________

              

      

      
        
           

        

        
           

          
            

          

        

        
           

        

      

    

     

    
      	
            	
              3.

            	
              Term and
      Termination.  Subject to earlier termination, the term of
      this agreement shall begin on the date set forth above and will continue
      in full force and effect for a period of twelve (12)
      months.  Thereafter, the parties may renew this Agreement upon
      mutually agreeable terms.  Upon any termination or expiration of
      this Agreement, Company shall pay all unpaid and outstanding fees, through
      the effective date of termination or expiration of this Agreement. And
      upon such termination, Consultant shall provide and deliver to Company any
      and all outstanding Services due through the effective date of this
      Agreement.  Termination by either party shall not result in the
      forfeiture by Consultant of the Shares or right to a written legal opinion
      regarding the tradability of the
Shares.

            

    

     

    
      	
            	
              4.

            	
              Independent Contractor
      Status.  The parties agree and acknowledge that that this
      Agreement shall not be construed so as to make either an employee of the
      other and neither party shall hold themselves out as
      such.  Neither party shall i) have the authority bind the other
      to any contract, agreement, nor indenture; ii) be liable to any third
      party for the acts of the other; nor iii) accept service of process for
      the other.

            

    

     

    
      	
            	
              5.

            	
              Confidential
      Information.  It is agreed by the parties that Consultant
      may have access to, have disclosed to it, or otherwise obtain Confidential
      Information about the Company.  “Confidential Information” shall mean
      confidential, non-public or other proprietary information including,
      without limitation, letters addressed from the Securities and Exchange
      Commission to the Company, trade secrets, technical information, including
      algorithms, code, data, designs, documentation, drawings, formulae,
      hardware, know-how, ideas, inventions, whether patentable or not,
      photographs, plans, procedures, processes, reports, research, samples,
      sketches, software, specifications, business information, including
      customer and distributor names, marketing information, operations, plans,
      products, financial information, including pricing and other confidential
      information that is disclosed under the terms of this Agreement by the
      Company or the Consultant.  Consultant shall not disclose to, or
      use for the benefit of, any third party, Confidential Information it
      receives without the prior written consent of the
      Company.  Information shall not be considered Confidential
      Information if such information is i) already known to Consultant at the
      time it is obtained, ii) subsequently learned from an independent third
      party; or iii) available publicly.

            

    

     

    
      	
            	
              6.

            	
              Confidentiality of
      Agreement.  The parties shall not disclose to any third
      person or entity, any portion of this Agreement except as necessary for
      the Consultant to provide the Services set forth in Section 1
      herein.  Neither party shall disclose the existence or terms of
      this Agreement without first obtaining prior written approval of the other
      party which approval may be withheld by Consultant for any
      reason.  Neither party shall use the other’s name, logo,
      trademarks, or service marks in any advertising, publicity releases, or
      any other materials without that party’s prior written approval, which
      shall not be unreasonably withheld by the Company if Consultant determines
      such use to be consistent with the performance of its Services described
      herein.

            

    

     

    
      
        	
                ICS
      Consulting Agreement 001

              	
                3

              	
                Initial______________

              

      

      
        
           

        

        
           

          
            

          

        

        
           

        

      

    

     

    
      	
            	
              7.

            	
              Best
      Efforts.  The parties agree that Consultant will utilize
      its best efforts to provide the Services set forth in Section 1
      above.  The Company acknowledges and accepts that Consultant
      does not and cannot promise or guarantee that any specific result can or
      will be achieved by the Consultant as a result of its performance of the
      Services set forth herein.

            

    

     

    
      	
            	
              8.

            	
              Assignment.  This
      Agreement shall be assigned to and inure to the benefit of, and be binding
      upon, any successor to substantially all of the assets and business of the
      Company as a going concern, whether by merger, consolidation, liquidation
      or sale of substantially all of the assets of the Company or
      otherwise.  The Company will require any successor (whether
      direct or indirect, by purchase, merger, consolidation or otherwise) to
      all or substantially all of the business and/or assets of the Company to
      assume expressly and agree to perform this Agreement in the same manner
      and to the same extent that the Company would be required to perform as if
      no such succession had taken place; and, as used in this Agreement,
      "Company" shall mean the Company as hereinbefore defined and any successor
      to its business and/or assets as aforesaid which assumes and agrees to
      perform this Agreement by operation of law, or otherwise; provided that
      for purposes of Section 8 hereof, the term “Company” shall mean the
      Company as hereinbefore defined and any such transaction in which this
      Agreement is assigned to a successor may not expand or enlarge the scope
      of restrictions applicable to Consultant pursuant to this
      Agreement.  Consultant understands and agrees, however, that
      this Agreement is exclusive and personal to him only, and, as such, he
      will neither assign nor subcontract all or part of his undertaking(s) or
      obligation(s) under the terms of this
Agreement.

            

    

     

    
      	
            	
              9.

            	
              Suit/Jurisdiction.  The
      parties agree that any and all disputes rising out of or relating to this
      Agreement shall be submitted to the American Arbitration Association
      (“AAA”) for binding and final resolution in accordance with the rules of
      the AAA.  The parties further agree that such arbitration shall
      take place in California, as up to Consultant’s sole
      discretion.  Notwithstanding the foregoing, the parties shall
      each retain the right to seek injunctive or equitable relief for any
      actual or threatened breach of Sections 5 and 6 of this
      Agreement.  In the event either party exercises its right to
      seek injunctive or equitable relief, it shall do so in a court of
      competent jurisdiction in the State of California or such other
      jurisdiction as Consultant in its sole discretion shall
      choose.  The choice of law shall be the law of the State of
      California.  Without limitation of the foregoing, each party
      acknowledges that it hereby waives the right to have disputes rising out
      of or relating to this Agreement resolved by jury
  trial.

            

    

    

      
        	
                ICS
      Consulting Agreement 001

              	
                4

              	
                Initial______________

              

      

      
        
           

        

        
           

          
            

          

        

        
           

        

      

    

     

    
      	
            	
              10.

            	
              Interpretation of
      Agreement.  This Agreement shall be interpreted in
      accordance plain meaning of its terms and under the laws of the State of
      California.

            

    

     

    
      	
            	
              11.

            	
              Contents of Agreement
      and Amendments.  This Agreement set forth the entire
      agreement of the parties.  No amendment or modification to this
      Agreement shall be binding unless in writing and signed by both
      parties.

            

    

     

    
      	
            	
              12.

            	
              Counterparts; Delivery
      by Facsimile. This Agreement may be executed in one or more
      counterparts, each of which shall be deemed an original, but all of which
      together shall constitute one and the same instrument. Delivery of this
      Agreement may be affected by
facsimile.

            

    

    

      
        	
                ICS
      Consulting Agreement 001

              	
                5

              	
                Initial______________

              

      

      
        
           

        

        
           

          
            

          

        

        
           

        

      

    

     

    IN
WITNESS WHEREOF, the parties have executed this Agreement effective as of the
date and year first written above.

     

    
      
        
          
            
              	
                      CONSULTANT:

                    	 
      	
                      COMPANY:

                       

                    
	
                      Ice
      Cold Stocks

                    	 
      	
                      Lantis
      Laser Inc. (LLSR)

                    
	 	 	 
	/s/
      Debbie Sutz	 
      	
                      /s/ Stan
      Baron

                    
	
                      Print
      Name: Debbie Sutz

                    	 
      	
                      Print
      Name: Stan Baron

                    
	
                      Title:
      President

                    	 
      	
                      Title:
      President & CEO

                    
	
                      Dated:
      11/15/2007

                    	
                        

                    	
                      Dated:11/15/2006

                    

            

          

        

      

    

    

      
        	
                ICS
      Consulting Agreement 001

              	
                6

              	
                Initial______________EXHIBIT
10.13

     

    Third
Addendum to the Technology License Agreement

     

    between

     

    The
Research Foundation of State University of New York

     

    for
and on behalf of University at Buffalo

     

    and

     

    Donald
D. Hickey, M.D.

     

    and

     

     Clas
E. Lundgren, M.D., Ph.D.

     

    and

     

    Scivanta
Medical Corporation

    

    This
Third Addendum (this “Third Addendum”) to the Technology License Agreement (as
such term is defined below), entered into as of the 6th day of January, 2009
(the “Third Addendum Effective Date”), is by and among The Research Foundation
of State University of New York, for and on behalf of University at Buffalo, a
non-profit corporation organized and existing under the laws of the State of New
York (the “Foundation”), Donald D. Hickey, M.D. (“Hickey”) and Clas E. Lundgren,
M.D., Ph.D. (a/k/a Claes Lundgren and referenced herein as “Lundgren”) and
Scivanta Medical Corporation (formerly Medi-Hut Co., Inc.), a corporation duly
organized under the laws of the State of Nevada, and having its principal place
of business at 215 Morris Avenue, Spring Lake, New Jersey 07762
(“Licensee”).  Foundation, Hickey and Lundgren will be collectively
referenced herein as “Licensor.”  Capitalized terms used herein, but
not otherwise defined herein, shall have such meanings as given to such terms in
the Technology License Agreement.

    

    WHEREAS,
Licensor and Licensee entered into an exclusive Technology License Agreement on
November 10, 2006, as amended on each of June 29, 2007 and October 24, 2008 (the
“Technology License Agreement”), to facilitate the development and
commercialization of certain technology owned by Licensor so that this
technology may be utilized to the fullest extent for the benefit of Licensee,
Licensor, the inventor(s) and the public; and

     

    WHEREAS,
Licensor and Licensee desire to modify the aforementioned Technology License
Agreement for the mutual benefit of both parties;

     

    NOW,
THEREFORE, in consideration of the mutual promises and covenants contained
herein, and for other good and valuable consideration, the receipt of which is
hereby acknowledged, the parties agree as follows:

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      	
              1.

            	
              The
      modifications of the Technology License Agreement herein will be effective
      as of the Third Addendum Effective Date and will remain in effect for the
      duration of the Technology License Agreement unless further modified in
      writing by the parties hereto.

            

    

    

    
      	
              2.

            	
              Licensor
      agrees that the milestones listed in Section 4.2(a) of the Technology
      License Agreement have been completed by the Licensee within an acceptable
      timeframe as provided by the Technology License
  Agreement.

            

    

    

    
      	
              3.

            	
              The
      first line of Section 4.2(b) will be deleted in its entirety and replaced
      with the following:

            

    

    

    
      	
               
      

            	
              (b)

            	
              On
      or before September 30, 2009, Licensee
will:

            

    

     

    
      	
              4.

            	
              The
      first line of Section 4.2(c) will be deleted in its entirety and replaced
      with the following:

            

    

    

    
      	
               
      

            	
              (c)

            	
              On
      or before September 30, 2009, Licensee
will:

            

    

     

    
      	
              5.

            	
              Section
      4.2(d) will be deleted in its entirety and replaced with the
      following:

            

    

    

    
      	
               
      

            	
              (d)

            	
              Within
      twenty-four (24) months from the date the Licensed Product is approved by
      the FDA for marketing in the U.S., Licensee will, on its own or through a
      Sublicensee, gain approval to market the device in
  Japan.

            

    

     

    
      	
              6.

            	
              Other
      than as specifically modified in this Third Addendum, all other terms,
      conditions and covenants of the Technology License Agreement shall remain
      in full force and effect.

            

    

     

    IN
WITNESS WHEREOF, the undersigned duly authorized representatives of the parties
have executed this Third Addendum, effective as of the Third Addendum Effective
Date.

     

    
      
        
          
            
              
                
                  
                    
                      
                        
                          
                            
                              
                                	
                                        SCIVANTA MEDICAL CORPORATION

                                      	 
      	
                                        THE
      RESEARCH FOUNDATION OF

                                      
	 
      	 
      	 
      	
                                        STATE
      UNIVERSITY OF

                                      
	 
      	 
      	 
      	
                                        NEW
      YORK

                                      
	 
      	 
      	 
      	 
      	 
      
	
                                        By:

                                      	
                                        /s/
      David R. LaVance

                                      	 
      	
                                        By:

                                      	
                                        /s/
      Woodrow W. Maggard

                                      
	 
      	
                                        David
      R. LaVance

                                      	 
      	 
      	
                                        Woodrow
      W. Maggard

                                      
	 
      	 
      	 
      	 
      	 
      
	
                                        Title:  President
      and Chief Executive Officer

                                      	 
      	
                                        Title:
      Associate Vice Provost, STOR

                                      
	 
      	 
      	 
      	 
      	 
      
	
                                        DONALD
      D. HICKEY, M.D.

                                      	 
      	
                                        CLAS
      E. LUNDGREN, M.D., Ph.D.

                                      
	 
      	 
      	 
      	 
      	 
      
	
                                        By:

                                      	
                                        /s/
      Donald D. Hickey

                                      	 
      	
                                        By:

                                      	
                                        /s/
      Clas E. Lundgren

                                      
	 
      	
                                        Donald
      D. Hickey, M.D.

                                      	 
      	 
      	
                                        Clas
      E. Lundgren, M.D.,
Ph.D.

                                      

                              

                            

                          

                        

                      

                    

                  

                

              

            

          

        

      

    

     

    
      
        
        

      

      
        2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00152-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00152-of-00352.parquet"}]]